US Broker Ratings

Gilead Sciences, Inc. (GILD) Stock Analysis: Unpacking a 14.74% Potential Upside for Investors

In the ever-evolving landscape of the healthcare sector, Gilead Sciences, Inc. (NASDAQ: GILD) stands out as a biopharmaceutical titan with a robust portfolio in addressing unmet medical needs. With a..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 26.90% Potential Upside in Healthcare Innovation

Intuitive Surgical, Inc. (NASDAQ: ISRG) remains a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Sunnyvale, California, this $169.76 billion market cap..

Tenet Healthcare Corporation (THC) Stock Analysis: A 30% Potential Upside Beckons Investors

Tenet Healthcare Corporation (NYSE: THC) presents a compelling opportunity for investors seeking exposure in the healthcare sector, thanks to its robust market position and promising growth potential. Despite recent price..

GE HealthCare Technologies Inc. (GEHC) Investor Outlook: Exploring a 33.6% Potential Upside

As investors navigate the dynamic landscape of the healthcare sector, GE HealthCare Technologies Inc. (NYSE: GEHC) presents a compelling opportunity. With a substantial market cap of $31.78 billion, this Chicago-based..

Mettler-Toledo International (MTD) Stock Analysis: Strong Revenue Growth and Potential 24.97% Upside

Mettler-Toledo International Inc. (NYSE: MTD), a leader in precision instruments and services, is attracting investor attention with its solid revenue growth and significant potential upside. The Swiss-based company, operating within..

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..

ResMed Inc. (RMD) Stock Analysis: Unlocking a Potential 31% Upside for Investors

ResMed Inc. (RMD), a pivotal player in the healthcare sector, is carving its niche in the medical instruments and supplies industry. With a robust market capitalization of $32.99 billion, ResMed..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a Promising 12.96% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR), a key player in the healthcare sector, is making waves with its innovative approach to addressing chronic and life-threatening diseases. With a market capitalization of..

Quest Diagnostics (DGX) Stock Analysis: Navigating Growth with 11.90% Potential Upside

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the healthcare sector, specializes in diagnostics and research services across the United States. With a broad spectrum of diagnostic offerings and..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 30.7% Upside Potential Amidst Strong Revenue Growth

Elevance Health, Inc. (NYSE: ELV), a key player in the healthcare plans industry, presents a compelling opportunity for investors seeking exposure in the healthcare sector. With a market capitalization of..

Medtronic plc (MDT) Stock Analysis: Unpacking a 29% Potential Upside in the Medical Device Giant

Medtronic plc (MDT), a leading player in the healthcare sector, has garnered significant attention from investors, particularly given its impressive market cap of $110.62 billion. Based in Ireland, Medtronic operates..

Regeneron Pharmaceuticals, Inc. (REGN) Investor Outlook: A Biotechnology Powerhouse with 19% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a dominant force in the biotechnology sector, offers a compelling opportunity for individual investors seeking exposure to healthcare innovation. With a robust market cap of..

Labcorp Holdings Inc. (LH) Stock Analysis: A 17% Potential Upside and Strong Buy Ratings Stand Out

Labcorp Holdings Inc. (NYSE: LH) is a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $21.8 billion, Labcorp provides essential..

Becton, Dickinson and Company (BDX) Stock Analysis: Unpacking a 27.91% Potential Upside for Investors

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, is capturing investor attention with a compelling potential upside of 27.91% according to recent analyst ratings. With a..

Sanofi (SNY) Stock Analysis: Exploring a 29% Potential Upside Amid Strategic Collaborations

Sanofi (NASDAQ: SNY), a titan in the healthcare sector and a leading figure in the Drug Manufacturers – General industry, is making waves with a substantial market capitalization of $108.62..

GSK plc (GSK) Stock Analysis: Evaluating a Solid 10.87% Potential Upside with a Strong Dividend Yield

GSK plc (GSK), a prominent name in the healthcare sector, has long been a stalwart in the drug manufacturing industry. With a robust market capitalization of $104.12 billion, GSK stands..

Boston Scientific Corporation (BSX) Stock Analysis: Unveiling a 47.5% Upside Potential in the Medical Device Industry

Boston Scientific Corporation (NYSE: BSX), a prominent player in the healthcare sector, continues to capture investor attention with its robust market presence in the medical devices industry. Based in the..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Exploring a 43.93% Potential Upside in Biotech

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its innovative approach and robust pipeline of therapeutics based on..

The Cigna Group (CI) Stock Analysis: Exploring a 28.90% Upside Potential in Healthcare Plans

The Cigna Group (NYSE: CI) stands as a formidable player in the healthcare sector, particularly within the healthcare plans industry. With a market capitalization of $70.21 billion, The Cigna Group..

Thermo Fisher Scientific Inc (TMO): Investor Outlook on a Potential 39.96% Upside

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a titan in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $176.23 billion, this Waltham,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds